119 related articles for article (PubMed ID: 1587410)
1. Increased collagen type III synthesis by fibroblasts isolated from strictures of patients with Crohn's disease.
Stallmach A; Schuppan D; Riese HH; Matthes H; Riecken EO
Gastroenterology; 1992 Jun; 102(6):1920-9. PubMed ID: 1587410
[TBL] [Abstract][Full Text] [Related]
2. Noncanonical STAT3 activation regulates excess TGF-β1 and collagen I expression in muscle of stricturing Crohn's disease.
Li C; Iness A; Yoon J; Grider JR; Murthy KS; Kellum JM; Kuemmerle JF
J Immunol; 2015 Apr; 194(7):3422-31. PubMed ID: 25740948
[TBL] [Abstract][Full Text] [Related]
3. Reversal of abnormal collagen production in Crohn's disease intestinal biopsies treated with regenerating agents.
Alexakis C; Caruelle JP; Sezeur A; Cosnes J; Gendre JP; Mosnier H; Beaugerie L; Gallot D; Malafosse M; Barritault D; Kern P
Gut; 2004 Jan; 53(1):85-90. PubMed ID: 14684581
[TBL] [Abstract][Full Text] [Related]
4. Stricturing Crohn's Disease Single-Cell RNA Sequencing Reveals Fibroblast Heterogeneity and Intercellular Interactions.
Mukherjee PK; Nguyen QT; Li J; Zhao S; Christensen SM; West GA; Chandra J; Gordon IO; Lin S; Wang J; Mao R; Czarnecki D; Rayan C; Goren I; Banerjee S; Kotak P; Plesec T; Lal S; Fabre T; Asano S; Bound K; Hart K; Park C; Martinez R; Dower K; Wynn TA; Hu S; Naydenov N; Decaris M; Turner S; Holubar SD; Steele SR; Fiocchi C; Ivanov AI; Kravarik KM; Rieder F
Gastroenterology; 2023 Nov; 165(5):1180-1196. PubMed ID: 37507073
[TBL] [Abstract][Full Text] [Related]
5. Crohn's disease: evidence for involvement of unregulated transcytosis in disease etio-pathogenesis.
Pravda J
World J Gastroenterol; 2011 Mar; 17(11):1416-26. PubMed ID: 21472099
[TBL] [Abstract][Full Text] [Related]
6. Stricture formation in Crohn's disease: the role of intestinal fibroblasts.
Regan MC; Flavin BM; Fitzpatrick JM; O'Connell PR
Ann Surg; 2000 Jan; 231(1):46-50. PubMed ID: 10636101
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of small bowel TGFβ1 and TGFβ3 characterizes intestinal strictures in patients with fibrostenotic Crohn's disease.
Levitte S; Khan I; Iyahen V; Ziai J; Gubatan J; Sheng R; Glickstein SB; Sun T; Park KT; McBride J; Keir M
Histochem Cell Biol; 2024 May; ():. PubMed ID: 38705911
[TBL] [Abstract][Full Text] [Related]
8. Fibrostenosing Crohn's Disease: Pathogenetic Mechanisms and New Therapeutic Horizons.
Mignini I; Blasi V; Termite F; Esposto G; Borriello R; Laterza L; Scaldaferri F; Ainora ME; Gasbarrini A; Zocco MA
Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928032
[TBL] [Abstract][Full Text] [Related]
9. Measurement of Fibrosis in Crohn's Disease Strictures with Imaging and Blood Biomarkers to Inform Clinical Decisions.
Higgins PD
Dig Dis; 2017; 35(1-2):32-37. PubMed ID: 28147365
[TBL] [Abstract][Full Text] [Related]
10. Fibrostricturing Crohn's disease is marked by an increase in active eosinophils in the deeper layers.
Jacobs I; Ke BJ; Ceulemans M; Cremer J; D'Hoore A; Bislenghi G; Matteoli G; De Hertogh G; Sabino J; Ferrante M; Vermeire S; Breynaert C; Vanuytsel T; Verstockt B
Clin Transl Gastroenterol; 2024 May; ():. PubMed ID: 38690831
[TBL] [Abstract][Full Text] [Related]
11. Stricturing Crohn's disease single-cell RNA sequencing reveals fibroblast heterogeneity and intercellular interactions.
Mukherjee PK; Nguyen QT; Li J; Zhao S; Christensen SM; West GA; Chandra J; Gordon IO; Lin S; Wang J; Mao R; Czarnecki D; Rayan C; Kotak P; Plesec T; Lal S; Fabre T; Asano S; Bound K; Hart K; Park C; Martinez R; Dower K; Wynn TA; Hu S; Naydenov N; Decaris M; Turner S; Holubar SD; Steele SR; Fiocchi C; Ivanov AI; Kravarik KM; Rieder F
bioRxiv; 2023 Apr; ():. PubMed ID: 37066202
[TBL] [Abstract][Full Text] [Related]
12. Single cell sequencing data identify distinct B cell and fibroblast populations in stricturing Crohn's disease.
Humphreys DT; Lewis A; Pan-Castillo B; Berti G; Mein C; Wozniak E; Gordon H; Gadhok R; Minicozzi A; ChinAleong J; Feakins R; Giannoulatou E; James LK; Stagg AJ; Lindsay JO; Silver A
J Cell Mol Med; 2024 May; 28(9):e18344. PubMed ID: 38685679
[TBL] [Abstract][Full Text] [Related]
13. Identification of antigen-presentation related B cells as a key player in Crohn's disease using single-cell dissecting, hdWGCNA, and deep learning.
Shen X; Mo S; Zeng X; Wang Y; Lin L; Weng M; Sugasawa T; Wang L; Gu W; Nakajima T
Clin Exp Med; 2023 Dec; 23(8):5255-5267. PubMed ID: 37550553
[TBL] [Abstract][Full Text] [Related]
14. Intestinal strictures in Crohn's disease: An update from 2023.
Liu Z; Huang Z; Wang Y; Xiong S; Lin S; He J; Tan J; Liu C; Wu X; Nie J; Huang W; Zhang Y; Zhou L; Mao R
United European Gastroenterol J; 2024 Mar; ():. PubMed ID: 38546434
[TBL] [Abstract][Full Text] [Related]
15. Characterizing intestinal strictures of Crohn's disease
Lei H; Johnson LA; Eaton KA; Liu S; Ni J; Wang X; Higgins PDR; Xu G
Biomed Opt Express; 2019 May; 10(5):2542-2555. PubMed ID: 31143502
[TBL] [Abstract][Full Text] [Related]
16. A comprehensive metabolite fingerprint of fibrostenosis in patients with Crohn's disease.
Bos S; Lobatón T; De Vos M; Van Welden S; Plekhova V; De Paepe E; Vanhaecke L; Laukens D
Sci Rep; 2023 Dec; 13(1):23036. PubMed ID: 38155265
[TBL] [Abstract][Full Text] [Related]
17. Collagen content and types in the intestinal strictures of Crohn's disease.
Graham MF; Diegelmann RF; Elson CO; Lindblad WJ; Gotschalk N; Gay S; Gay R
Gastroenterology; 1988 Feb; 94(2):257-65. PubMed ID: 3335305
[TBL] [Abstract][Full Text] [Related]
18. Expression of transforming growth factors alpha and beta in colonic mucosa in inflammatory bowel disease.
Babyatsky MW; Rossiter G; Podolsky DK
Gastroenterology; 1996 Apr; 110(4):975-84. PubMed ID: 8613031
[TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor-beta 1 null mice. An animal model for inflammatory disorders.
Kulkarni AB; Ward JM; Yaswen L; Mackall CL; Bauer SR; Huh CG; Gress RE; Karlsson S
Am J Pathol; 1995 Jan; 146(1):264-75. PubMed ID: 7856732
[TBL] [Abstract][Full Text] [Related]
20. Aspergillus awamori: potential antioxidant, anti-inflammatory, and anti-apoptotic activities in acetic acid-induced ulcerative colitis in rats.
Abd-Ellatieff HA; Georg K; Abourawash AA; Ghazy EW; Samak DH; Goda WM
Inflammopharmacology; 2024 May; ():. PubMed ID: 38763983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
